NRP1 and breast carcinoma: Extrapolating from these observations, we hypothesized that the altered expression of NRP-1, its associated growth factors and commonly known partner molecules in PBMCs as well as plasma of breast cancer patients can serve as a good target to identify a potential biomarker for more personalized diagnostic and treatment plans.